Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness

NCT ID: NCT05823454

Last Updated: 2024-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-30

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness based on Electroencephalography and Auditory Event-related Potentials

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Consciousness Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Propofol

Intravenous infusion

Different drug dosage

Intervention Type DRUG

Choice of Anesthesia

Dexmedetomidine

Intravenous infusion

Different drug dosage

Intervention Type DRUG

Choice of Anesthesia

Esketamine

Intravenous infusion

Different drug dosage

Intervention Type DRUG

Choice of Anesthesia

Sevoflurane

Inhalation anesthesia

Different drug dosage

Intervention Type DRUG

Choice of Anesthesia

Remifentanil

Intravenous infusion

Different drug dosage

Intervention Type DRUG

Choice of Anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Different drug dosage

Choice of Anesthesia

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 - 65 years old, native Chinese speaker, dextromanuality;
* Chronic disorder of consciousness;
* Spinal cord electrical stimulator implantation under general anesthesia;
* Signed informed consent.

Exclusion Criteria

* Continuous sedation was administered within 72 hours prior to the study;
* Open head injury, parenchymatectomy and other damage of brain structural integrity;
* The intracranial compliance decreased due to hydrocephalus and swelling;
* Known hearing impairment;
* Airway stenosis and various causes of severe ventilation or ventilation dysfunction;
* Known or suspected cardiac dysfunction;
* Allergic to intravenous general anesthetics;
* Associated with other mental or neurological diseases;
* Other reasons are not suitable to participate in this study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Tiantan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ruquan Han

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Tiantan Hospital, Capital Medical University

Beijing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ruquan Han, M.D., Ph.D

Role: primary

8610-59976660

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ywn20220929

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sedation and Memory Consolidation
NCT05045170 COMPLETED NA
Perioperative Audio for Anaesthesia
NCT05291832 COMPLETED NA